Milvue

Deep learning detection and measurement on radiographs is the whole product. The Milvue Suite reads X-rays and returns findings, measurements, and a draft report; there is no scanner, PACS, or services layer of its own. One useful piece of candour: the company labels its report generation module as subscription software and explicitly NOT a medical device, separating the regulated detection engine from the unregulated reporting convenience layer, which is a distinction most vendors blur.

Detection plus a pre-filled draft report that the radiologist validates, with the company stating plainly that the user validates the output. This sits a step further toward automation than pure detection overlay, since generating draft report text shapes what the reader writes, but it stops well short of autonomous reporting. The clearance basis is a reader study measuring physician performance with the tool, which is the correct framing for an assistive device.

Headline performance is published, ROC-AUC above 96 percent for fractures and a reader study across 24 physicians of varying expertise reporting sensitivity improvements of 20 percent for fractures and 18 percent for elbow joint effusions plus reduced interpretation time. But the aggregate AUC figure is not broken out by pathology, anatomical region, or patient age, and the claim to be number one in adult and pediatric fractures is not substantiated against any named comparator or third party benchmark. Training data composition and architecture are not published.

Real evidence with real limits. The FDA clearance study involved 24 experienced physicians across musculoskeletal, radiology, and pediatric expertise levels, which tests the tool across the actual mix of readers who use it rather than radiologists alone. Peer reviewed work by Parpaleix and colleagues assessed the combined musculoskeletal and chest solution in an emergency setting. Deployment scale is substantial at a reported 25 million X-rays analysed in 2024 and 600 plus sites. What is missing is outcome level evidence and independent head to head comparison against the several competing fracture detection vendors now indexed here, which matters given how crowded that specific niche has become.

No specific PHI handling or data governance framework was located in the materials reviewed.

No HIPAA or BAA commitment was located. A France headquartered vendor now FDA cleared and selling into the US should be asked to establish business associate terms, particularly given the cloud deployment option.

No SOC 2, ISO 27001, or equivalent attestation and no trust center were located. EU MDR Class IIa certification via notified body BSI covers device safety and performance rather than information security.

Authorization across three jurisdictions with clearly delineated scope, which the company documents unusually precisely: the Milvue Suite is CE Class IIa under EU MDR 2017/745 via notified body BSI, TechCare Trauma is FDA cleared as a Class II device covering musculoskeletal detection and triage, a second FDA clearance covers chest, and Smart Trauma plus TechCare Metrics are Health Canada licensed Class II. Naming which specific product carries which authorization in which market, rather than claiming blanket global clearance, is exactly the disclosure discipline this axis rewards.

The clearance reader study spans physicians of differing expertise levels including pediatric specialists, and the product covers both adult and pediatric fractures, so age group generalization has been considered. No formal governance framework, post market monitoring commitment, or demographic subgroup performance analysis was located.

Integration into the RIS and PACS is the delivery mechanism, with results and a pre-filled report returned inside 30 seconds into the systems radiologists already use. Availability through the Blackford imaging platform provides a second route for customers already running that marketplace, alongside the direct path. Support for 17 or more languages and deployment across five geographic regions indicates the integration generalizes beyond one national environment. Radiology workflow integration; no EHR integration claimed.

Better disclosed than most peers because the choice is explicit: the solution is available via secure cloud platform OR on-premises deployment. Offering a genuine on-premise option matters for institutions unwilling to send imaging outside their perimeter, and few competitors in this lane state it plainly. Specific tenancy and data residency terms for the cloud option are not published.

No pricing is published. Scale is disclosed rather than cost, 25 million X-rays analysed in 2024 across 600 plus sites, and a second procurement route exists via the Blackford platform with presumably different economics. The suite structure means a buyer should establish which modules are licensed, since detection, the 60 automatic measurements, and the report generation layer are distinct components with different regulatory status.

Broad within plain radiography and deliberately so: seven pathology families spanning trauma and chest, adult and pediatric, plus 60 automatic measurements covering full legs, hip and pelvis, foot, shoulder, spine, knee, vertebrae, EOS, and bone age. Serving radiologists, emergency physicians, and orthopedic specialists across private practices, university hospitals, and teleradiology groups. The measurement suite alongside detection is a genuine differentiator, since most competitors do one or the other. Confined to X-ray rather than spanning CT and MRI.